WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011143457) COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ATRIAL FIBRILLATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/143457    International Application No.:    PCT/US2011/036291
Publication Date: 17.11.2011 International Filing Date: 12.05.2011
IPC:
A61K 31/4704 (2006.01), A61K 31/138 (2006.01), A61K 31/135 (2006.01), A61K 31/535 (2006.01), A61P 9/04 (2006.01)
Applicants: NORTHWESTERN UNIVERSITY [US/US]; 633 Clark Street Evanston, IL 60208 (US) (For All Designated States Except US).
ARORA, Rishi [US/US]; (US) (For US Only).
ZEMBOWER, David, E. [US/US]; (US)
Inventors: ARORA, Rishi; (US).
ZEMBOWER, David, E.; (US)
Agent: STAPLE, David, W.; 2275 Deming Way, Suite 310 Middleton, Wisconsin 53562 (US)
Priority Data:
61/334,023 12.05.2010 US
61/409,691 03.11.2010 US
Title (EN) COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING ATRIAL FIBRILLATION
(FR) COMPOSITIONS ET MÉTHODES PERMETTANT DE TRAITER OU DE PRÉVENIR LA FIBRILLATION AURICULAIRE
Abstract: front page image
(EN)The present invention provides compositions and methods for treating or preventing atrial fibrillation (AF). In particular, the present invention provides administration of muscarinic receptor antagonists (e.g., M2-selective muscarinic receptor blockers), administered alone or in combination with other therapeutic agents (e.g., beta-adrenergic receptor blockers) to treat and/or prevent atrial fibrillation.
(FR)La présente invention concerne des compositions et des méthodes permettant de traiter ou de prévenir la fibrillation auriculaire (FA). La présente invention concerne, en particulier, l'administration d'antagonistes des récepteurs muscariniques (par exemple d'inhibiteurs sélectifs des récepteurs muscariniques M2), seuls ou en association avec d'autres agents thérapeutiques (par exemple des inhibiteurs des récepteurs bêta-adrénergiques) pour traiter et/ou prévenir la fibrillation auriculaire.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)